Literature DB >> 19139002

Delphinidin attenuates neoplastic transformation in JB6 Cl41 mouse epidermal cells by blocking Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling.

Nam Joo Kang1, Ki Won Lee, Jung Yeon Kwon, Mun Kyung Hwang, Evgeny A Rogozin, Yong-Seok Heo, Ann M Bode, Hyong Joo Lee, Zigang Dong.   

Abstract

Recent studies suggest that anthocyanidins play a pivotal role in the chemopreventive effects of fruits and vegetables. However, the underlying molecular mechanisms and cellular targets remain unknown. Neoplastic transformation of cells and inflammation are considered to be major events contributing to carcinogenesis. Here, we report that delphinidin, a major dietary anthocyanidin, inhibits tumor promoter-induced transformation and cyclooxygenase-2 (COX-2) expression in JB6 promotion-sensitive mouse skin epidermal (JB6 P+) cells by directly targeting Raf and mitogen-activated protein kinase kinase (MEK). Delphinidin inhibited 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced neoplastic transformation and COX-2 expression at both the protein and transcriptional levels. The activation of activator protein-1 and nuclear factor-kappaB induced by TPA was dose dependently inhibited by delphinidin treatment. Delphinidin strongly suppressed Raf1 and MEK1 kinase activities and subsequently attenuated TPA-induced phosphorylation of MEK, extracellular signal-regulated kinase (ERK), p90RSK, and MSK. Although delphinidin suppressed ERK and c-Jun NH(2)-terminal kinase activities, it was more effective at inhibiting Raf1 or MEK1 activities. Pull-down and competition assays revealed that delphinidin binds with Raf1 or MEK1 noncompetitively with ATP. Delphinidin also dose dependently suppressed JB6 P+ cell transformation induced by epidermal growth factor and H-Ras, both of which are involved in the activation of Raf/MEK/ERK signaling. Together, these findings suggested that the targeted inhibition of Raf1 and MEK activities and COX-2 expression by delphinidin contribute to the chemopreventive potential of fruits and vegetables.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19139002      PMCID: PMC2832759          DOI: 10.1158/1940-6207.CAPR-08-0071

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  44 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Signal transduction pathways: targets for chemoprevention of skin cancer.

Authors:  A M Bode; Z Dong
Journal:  Lancet Oncol       Date:  2000-11       Impact factor: 41.316

3.  Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice.

Authors:  N Chen; M Nomura; Q B She; W Y Ma; A M Bode; L Wang; R A Flavell; Z Dong
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

4.  Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line.

Authors:  G Liu; A Bode; W Y Ma; S Sang; C T Ho; Z Dong
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

5.  Effects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines.

Authors:  S Chen; Q Ruan; E Bedner; A Deptala; X Wang; T C Hsieh; F Traganos; Z Darzynkiewicz
Journal:  Cell Prolif       Date:  2001-10       Impact factor: 6.831

6.  NS-398 and piroxicam suppress UVB-induced activator protein 1 activity by mechanisms independent of cyclooxygenase-2.

Authors:  Guangming Liu; Wei-Ya Ma; Ann M Bode; Yiguo Zhang; Zigang Dong
Journal:  J Biol Chem       Date:  2002-11-13       Impact factor: 5.157

Review 7.  Inflammation and cancer: back to Virchow?

Authors:  F Balkwill; A Mantovani
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

Review 8.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials.

Authors:  J I Johnson; S Decker; D Zaharevitz; L V Rubinstein; J M Venditti; S Schepartz; S Kalyandrug; M Christian; S Arbuck; M Hollingshead; E A Sausville
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

10.  AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model.

Authors:  Kazumi Suzukawa; Thomas J Weber; Nancy H Colburn
Journal:  Environ Health Perspect       Date:  2002-09       Impact factor: 9.031

View more
  12 in total

1.  Elevated phosphate activates N-ras and promotes cell transformation and skin tumorigenesis.

Authors:  Corinne E Camalier; Matthew R Young; Gerd Bobe; Christine M Perella; Nancy H Colburn; George R Beck
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-09

Review 2.  Effects of anthocyanins on the prevention and treatment of cancer.

Authors:  Bo-Wen Lin; Cheng-Chen Gong; Hai-Fei Song; Ying-Yu Cui
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

Review 3.  Molecular targets of phytochemicals for cancer prevention.

Authors:  Ki Won Lee; Ann M Bode; Zigang Dong
Journal:  Nat Rev Cancer       Date:  2011-02-10       Impact factor: 60.716

Review 4.  Signal transduction and molecular targets of selected flavonoids.

Authors:  Ann M Bode; Zigang Dong
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

5.  Fucoxanthin Elicits Epigenetic Modifications, Nrf2 Activation and Blocking Transformation in Mouse Skin JB6 P+ Cells.

Authors:  Yuqing Yang; Irene Yang; Mingnan Cao; Zheng-Yuan Su; Renyi Wu; Yue Guo; Mingzhu Fang; Ah-Ng Kong
Journal:  AAPS J       Date:  2018-02-20       Impact factor: 4.009

Review 6.  Diet phytochemicals and cutaneous carcinoma chemoprevention: A review.

Authors:  Siliang Wang; Peiliang Shen; Jinrong Zhou; Yin Lu
Journal:  Pharmacol Res       Date:  2017-02-24       Impact factor: 10.334

7.  Delphinidin Inhibits HER2 and Erk1/2 Signaling and Suppresses Growth of HER2-Overexpressing and Triple Negative Breast Cancer Cell Lines.

Authors:  Tuba Ozbay; Rita Nahta
Journal:  Breast Cancer (Auckl)       Date:  2011-07-12

8.  EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC.

Authors:  Jiao Meng; Cuicui Chang; Yuhua Chen; Fangfang Bi; Chen Ji; Wei Liu
Journal:  Onco Targets Ther       Date:  2019-07-26       Impact factor: 4.147

9.  Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer.

Authors:  Raju Dash; Mir Muhammad Nasir Uddin; S M Zahid Hosen; Zahed Bin Rahim; Abu Mansur Dinar; Mohammad Shah Hafez Kabir; Ramiz Ahmed Sultan; Ashekul Islam; Md Kamrul Hossain
Journal:  Bioinformation       Date:  2015-12-31

Review 10.  Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention.

Authors:  Simona Izzo; Valeria Naponelli; Saverio Bettuzzi
Journal:  Nutrients       Date:  2020-04-06       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.